Cite
HARVARD Citation
O'Malley, D. et al. (2022). Pembrolizumab in Patients With Microsatellite Instability–High Advanced Endometrial Cancer: Results From the KEYNOTE-158 Study. Journal of clinical oncology. 40 (7), pp. 752-761. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
O'Malley, D. et al. (2022). Pembrolizumab in Patients With Microsatellite Instability–High Advanced Endometrial Cancer: Results From the KEYNOTE-158 Study. Journal of clinical oncology. 40 (7), pp. 752-761. [Online].